Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

EQRX

EQRx (EQRX)

EQRx Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:EQRX

Date	Heure	Source	Titre	Symbole	Société
20/11/2023	22h00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:EQRX	EQRx Inc
20/11/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EQRX	EQRx Inc
09/11/2023	22h13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EQRX	EQRx Inc
09/11/2023	22h05	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:EQRX	EQRx Inc
09/11/2023	22h03	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:EQRX	EQRx Inc
09/11/2023	15h29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQRX	EQRx Inc
08/11/2023	17h30	GlobeNewswire Inc.	Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition	NASDAQ:EQRX	EQRx Inc
06/11/2023	22h10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EQRX	EQRx Inc
01/11/2023	13h02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:EQRX	EQRx Inc
01/11/2023	12h59	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:EQRX	EQRx Inc
01/08/2023	13h00	GlobeNewswire Inc.	Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital	NASDAQ:EQRX	EQRx Inc
08/05/2023	23h06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:EQRX	EQRx Inc
08/05/2023	22h01	GlobeNewswire Inc.	EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results	NASDAQ:EQRX	EQRx Inc
27/04/2023	14h00	GlobeNewswire Inc.	EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023	NASDAQ:EQRX	EQRx Inc
13/03/2023	14h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EQRX	EQRx Inc
23/02/2023	23h31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:EQRX	EQRx Inc
23/02/2023	22h08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:EQRX	EQRx Inc
23/02/2023	13h00	GlobeNewswire Inc.	EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress	NASDAQ:EQRX	EQRx Inc
22/02/2023	22h09	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:EQRX	EQRx Inc
09/02/2023	17h29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:EQRX	EQRx Inc
03/01/2023	14h00	GlobeNewswire Inc.	EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference	NASDAQ:EQRX	EQRx Inc
19/12/2022	14h00	GlobeNewswire Inc.	EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer	NASDAQ:EQRX	EQRx Inc
02/12/2022	14h00	GlobeNewswire Inc.	EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer	NASDAQ:EQRX	EQRx Inc
25/11/2022	22h08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:EQRX	EQRx Inc
10/11/2022	13h00	GlobeNewswire Inc.	EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial Results	NASDAQ:EQRX	EQRx Inc
07/11/2022	14h00	GlobeNewswire Inc.	EQRx to Participate in the Jefferies 2022 London Healthcare Conference	NASDAQ:EQRX	EQRx Inc
28/10/2022	14h00	GlobeNewswire Inc.	EQRx to Hold Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022	NASDAQ:EQRX	EQRx Inc
12/08/2022	22h10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:EQRX	EQRx Inc
12/08/2022	22h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:EQRX	EQRx Inc
11/08/2022	13h00	GlobeNewswire Inc.	EQRx Reports Second Quarter 2022 Financial Results and Recent Corporate Progress	NASDAQ:EQRX	EQRx Inc

Showing the most relevant articles for your search:NASDAQ:EQRX

Donnelley Financial Solu...

IT0005625865 20251201 350

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales